Title: 2018 ACVIM Forum Research Abstract Program: Seattle, Washington, June 14 - 15, 2018 Document date: 2018_10_25
ID: 60ceejq1_441
Snippet: The liver performs an essential role in metabolism of vitamin D (VD); deficiency of vitamin K, another fat-soluble vitamin, is common in cats with cholestatic hepatobiliary disease (CHD). We hypothesized that VD levels in cats with CHD would be significantly lower than in normal cats or sick cats with non-hepatobiliary disorders. A prospective case control study was done comparing cats with CHD disease (defined by hyperbilirubinemia and increased.....
Document: The liver performs an essential role in metabolism of vitamin D (VD); deficiency of vitamin K, another fat-soluble vitamin, is common in cats with cholestatic hepatobiliary disease (CHD). We hypothesized that VD levels in cats with CHD would be significantly lower than in normal cats or sick cats with non-hepatobiliary disorders. A prospective case control study was done comparing cats with CHD disease (defined by hyperbilirubinemia and increased alanine aminotransferase), sick cats without hepatobiliary disease, and normal cats repre- Sixty-nine studies, including seven conference abstracts, reporting perioperative and/or clinical and/or surgical/interventional outcomes of dogs managed with one surgical/interventional technique and/or medical management for cEHPSS were identified. Only 19 studies were designed as prospective studies, including one non-blinded randomized controlled clinical trial, one non-blinded non-randomized controlled clinical trial and 17 uncontrolled clinical trials. The majority of the studies showed overall high risk of bias and evaluated low to very low numbers of cases per treatment group (67%) but with clearly characterized subject enrolment criteria (97%).
Search related documents:
Co phrase search for related documents- alanine aminotransferase and cholestatic hepatobiliary disease: 1
- alanine aminotransferase and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- alanine aminotransferase and control study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- alanine aminotransferase and hepatobiliary disease: 1, 2, 3
- alanine aminotransferase and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alanine aminotransferase and increase alanine aminotransferase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- alanine aminotransferase and medical management: 1
- alanine aminotransferase and normal cat: 1
- alanine aminotransferase and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- alanine aminotransferase and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- alanine aminotransferase and treatment group case: 1
- bias high risk and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- bias high risk and conference abstract: 1, 2
- bias high risk and control study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- bias high risk and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- bias high risk and low number: 1, 2, 3, 4, 5, 6
- bias high risk and medical management: 1, 2
- bias high risk and overall bias high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
- bias high risk and prospective case: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date